Antibiotic Industry: How to Fix Its Infection | Fortunehttps://fortune.com/2019/11/14/antibiotics-funding-achaogen-tetraphase-pharmaceuticals/
Antibiotic resistance and pharmaceutical business modelsCARB-XDISARM Act model legislationTetraphase
Cost of innovation making fight against superbugs near impossible - Opinion - MM&M - Medical Marketing and Mediahttps://www.mmm-online.com/home/opinion/cost-of-innovation-making-fight-against-superbugs-near-impossible/
2019-02 Aradigm files for bankruptcy2019-04 Achaogen files for bankruptcy2019-12 Melinta files for bankruptcyDISARM Act model legislationTetraphase
Fighting ‘superbugs’ in Massachusetts (Guest viewpoint) - masslive.comhttps://www.masslive.com/opinion/2020/01/fighting-superbugs-in-massachusetts-guest-viewpoint.html
2019-04 Achaogen files for bankruptcyAntibiotic resistance and pharmaceutical business modelsDISARM Act model legislationTetraphase

Showing topic

Tetraphase
Pharmaceutical makers and biopharmaceutical companies